Does creatine cause hair loss?
"Creatine raises DHT and can accelerate hair loss" — that is the claim circulating on forums, in product reviews, and in cautionary threads aimed at men who lift. Strip it back and there is a real hormonal mechanism worth taking seriously, a single small study that people quote as if it were settled, and no direct evidence that creatine makes hair fall out. Those three things are not the same, and the gap between them is the whole story.
What is the true part of the claim?
The mechanism people invoke is genuine, so it is worth stating accurately before limiting it. Dihydrotestosterone, or DHT, is a potent androgen made from testosterone by the enzyme 5-alpha-reductase. In people genetically predisposed to androgenetic alopecia — the common pattern baldness that recedes at the temples and thins at the crown — DHT is the hormone that miniaturises hair follicles over years. This is established endocrinology. It is also why the licensed hair-loss drug finasteride works: it inhibits 5-alpha-reductase and lowers DHT.
So a substance that raised DHT would, in principle, have a plausible route to worsening hair loss in men already prone to it. That is a mechanism. It is not, on its own, evidence that creatine does this in practice.
Where does the cascade break?
The claim is built as a chain, and each link needs to hold for the conclusion to follow:
- DHT drives androgenetic alopecia — established.
- Creatine supplementation raises DHT — this rests on a single small trial.
- A raised DHT reading translates into more hair follicles miniaturising — not measured.
- That translates into visible, faster hair loss in the person taking creatine — not measured at all.
The chain is presented as if link one carries the whole weight. It does not. The claim being sold lives at link four — visible hair loss — and no study has measured hair count, hair density, shedding, or scalp coverage in people taking creatine. The reasoning walks from a real enzyme system all the way to a bathroom drain, and the measurement stops after the first step.
There is a missing condition, too. Even if creatine nudges DHT, the follicle response to DHT depends on individual androgen sensitivity, which is largely genetic. A hormonal reading changing in a group average tells you nothing about whether any given follicle crosses the threshold from healthy to miniaturising. That link is exactly the one the marketing needs and exactly the one nobody has looked at.
What did the DHT study actually find?
The entire hormonal claim traces back to one small trial in college-aged rugby players over three weeks (Clin J Sport Med, 2009), in which the dihydrotestosterone-to-testosterone ratio shifted while participants were taking creatine monohydrate. The distinction between that reading and a hair outcome is the whole argument.
It is a change in an exposure biomarker — a hormone level in the blood. It is not an intermediate outcome (a follicle changing), and it is certainly not a clinically meaningful outcome (hair you can see leaving your head). A single small, short trial reporting a hormonal shift has not been confirmed by replication, and it measured no hair-related endpoint whatsoever. Treating it as proof that creatine causes baldness asks one biomarker reading to do the work of an entire clinical trial that was never run.
Note also what "not confirmed" means here: it does not mean disproven. It means the finding sits alone, in a small sample, over a short window, with no hair outcome attached. That is a genuinely open question, not a settled danger.
Which word is doing the work?
Read the claim again: creatine "can accelerate hair loss." The load-bearing word is can. It asserts nothing falsifiable — no rate, no population, no probability — while implying a causal path from powder to scalp. Strip it out and the honest version reads: creatine was associated with a rise in one hormonal marker in one small study, and no study has measured hair. That sentence sells nothing, which is precisely why the marketing version keeps the softening verb.
Why do so many people believe it happened to them?
Personal reports are real experiences that deserve an explanation rather than dismissal. Several ordinary mechanisms produce exactly this belief even if creatine does nothing to hair:
- Timing overlap. Men often start creatine in their late teens and twenties — the same years androgenetic alopecia typically begins for those genetically predisposed. The hair loss was arriving regardless; the supplement was simply in the frame.
- Attribution after the fact. Once someone hears the DHT claim, ordinary daily shedding becomes evidence. Hair that would have gone unnoticed gets counted.
- Something else changed. Starting creatine often coincides with harder training, dieting, stress, or a new routine — any of which can affect shedding independently.
None of this proves creatine is innocent. It explains why confident personal testimony accumulates around a claim that the controlled data has never actually established.
Who should weigh this, and who can set it aside?
The evidence does not support telling everyone to avoid creatine over hair. It also does not support telling everyone the concern is baseless. The sensible split is by individual risk:
- Reasonable to weigh it: men with a strong family history of early male-pattern baldness, or who are already noticing recession or crown thinning. For this group the DHT mechanism is at least relevant, even though the hair outcome is unproven. If this describes you and hair matters to you, that is a conversation to have with a clinician who can assess your actual androgen-driven pattern — not a question a supplement label can answer.
- Reasonable to set aside: women, men with no predisposition to androgenetic alopecia, and anyone for whom the mechanism has no follicle to act on. For them the claim describes a pathway with no target.
The verdict, and a stopping rule
Does creatine cause hair loss? On the available evidence, the honest answer is: not shown, and plausibly a concern only for men already predisposed to male-pattern baldness. The DHT mechanism is real. The one study people cite moved a hormone marker, not a hair count. The step from biomarker to visible hair loss has never been measured, which means the confident version of the claim runs several rungs ahead of the data.
If you decide to take creatine and you are in the predisposed group, here is a criterion you can apply yourself: give it a defined window, watch your hairline honestly, and if you see a genuine change in shedding or density that concerns you, stop and reassess with a clinician rather than continuing out of habit. If nothing changes, the fear was theoretical. Either way, you are judging the outcome that matters — your hair — rather than a hormone reading somebody sold you as a warning.
On form, the practical point is unglamorous: the compound in question is plain creatine monohydrate, the only form with a large evidence base behind it, and the DHT question applies to creatine as such rather than to any particular product. Apply the criterion yourself to whatever you buy — plain monohydrate with third-party batch testing, in powder or in capsules such as Creatine Capsules — a fancier form changes nothing in the DHT question.
Sources
- Three weeks of creatine monohydrate supplementation affects dihydrotestosterone to testosterone ratio in college-aged rugby players (Clin J Sport Med, 2009) — the single trial the whole DHT claim rests on; it reports a hormone ratio, and measured no hair outcome.
- Creatine supplementation and DHT:T ratio in male rugby players (Clin J Sport Med, 2010) — correspondence and author reply — published discussion of the limits of that trial.
